|
FACTBOX-Timeline and facts about obesity drugs
Source: Reuters WASHINGTON, Sept 9 (Reuters) - Three new weight-loss drugs are up for Food and Drug Administration review this year. One is Arena Pharmaceuticals Inc's candidate Lorqess or lorcaserin, ...
www.alertnet.org
Diet drug urged off market
LOS ANGELES — The prescription diet drug sibutramine, sold under the brand name Meridia, should be taken off the market because it raises the risk of heart attacks and strokes in some patients, the editor of the New England Journal of Medicine said Sept. 2.
www.montereyherald.com
You Docs: Use your brain to help your body lose weight
If you're like most people, you can get a new body and save a bundle on pills by using your brain to diet smart instead of hard.
www.oregonlive.com
Losing weight in head
Like Lance Armstrong and the last-place Orioles, weight-loss pills have taken a beating in 2010. German researchers tested nine diet supplements and declared them all duds. An advisory committee suggested that the Food and Drug Administration reject a new diet drug called Qnexa. And the FDA forced two popular pounds-off pills (prescription Xenical and its over-the-counter sibling, Alli) to carry ...
www.postandcourier.com
Prescription diet drug raises risk of heart attack, stroke
Sibutramine, which alters brain chemicals to suppress appetite, carries risks for users with a history of cardiovascular disease. One doctor says it should be pulled off shelves. The prescription diet drug sibutramine, sold under the brand name Meridia, should be taken off the market because it raises the risk of heart attacks and strokes in some patients, the editor of the New England Journal ...
www.latimes.com
FDA urged to pull Abbott diet drug
Sibutramine, sold under the brand name Meridia, carries heart attack, stroke risks for users with a history of cardiovascular disease. The prescription diet drug sibutramine, sold under the brand name Meridia, should be taken off the market because it raises the risk of heart attacks and strokes in some patients, the editor of the New England Journal of Medicine said Wednesday.
www.chicagotribune.com
FDA urged to pull diet drug from market
Sibutramine, sold under the brand name Meridia, carries heart attacks, stroke risks for users with a history of cardiovascular disease. The prescription diet drug sibutramine, sold under the brand name Meridia, should be taken off the market because it raises the risk of heart attacks and strokes in some patients, the editor of the New England Journal of Medicine said Wednesday.
www.baltimoresun.com
Protein discovery may set target for Alzheimer's drugs
A new discovery by an 84-year-old scientist has illuminated a new direction in Alzheimer's research.
www.twincities.com
Study: Meridia raises risk of heart attack and stroke
Study: Meridia raises risk of heart attack and stroke
www.statesman.com
Diet drug Meridia should be withdrawn from market, journal editor says
LOS ANGELES — The prescription diet drug sibutramine, sold under the brand name Meridia, should be taken off the market because it raises the risk of heart attacks and strokes in some patients, the editor of the New England Journal of Medicine said today.
www.heraldnet.com
|
